Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Sputum%22&type0%5B%5D=Subject&op0%5B%5D=OR&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
/vufind/Search/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Sputum%22&type0%5B%5D=Subject&op0%5B%5D=OR&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
Search /vufind/Search2/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Sputum%22&type0%5B%5D=Subject&op0%5B%5D=OR&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
PubPharm (100)
1
AN INTERNATIONAL MULTICENTRE CONTROLLED CLINICAL TRIAL TO EVALUATE 1200MG AND 1800MG RIFAMPICIN DAILY IN THE REDUCTION OF TREATMENT DURATION FOR PULMONARY TUBERCULOSIS FROM 6 MONTHS TO 4 MONTHS (RIFASHORT) : AN INTERNATIONAL MULTICENTRE CONTROLLED CLINICAL TRIAL TO EVALUATE 1200MG AND 1800MG RIFAMPICIN DAILY IN THE REDUCTION OF TREATMENT DURATION FOR PULMONARY TUBERCULOSIS FROM 6 MONTHS TO 4 MONTHS (RIFASHORT)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
RIFAPENTINE-CONTAINING TUBERCULOSIS TREATMENT SHORTENING REGIMENS : RIFAPENTINE-CONTAINING TREATMENT SHORTENING REGIMENS FOR PULMONARY TUBERCULOSIS:A RANDOMIZED, OPEN-LABEL, CONTROLLED PHASE 3 CLINICAL TRIAL
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
INTERNATIONAL MULTICENTRIC TEST FOR THE EVALUATION OF A COMBINED TABLET OF FOUR DRUGS AT DAILY FIXED DOSE IN THE INTENSIVE INITIAL PHASE (2 MONTHS) OF CHEMOTHERAPY FOLLOWED BY A COMBINED TABLET OF TWO DRUGS AT A FIXED DOSE THREE TIMES A WEEK IN THE CONTINUATION PHASE (4 MONTHS) FOR THE TREATMENT OF PULMONARY TUBERCULOSIS : INTERNATIONAL MULTICENTRIC TEST FOR THE EVALUATION OF A COMBINED TABLET OF FOUR DRUGS AT DAILY FIXED DOSE IN THE INTENSIVE INITIAL PHASE (2 MONTHS) OF CHEMOTHERAPY FOLLOWED BY A COMBINED TABLET OF TWO DRUGS AT A FIXED DOSE THREE TIMES A WEEK IN THE CONTINUATION PHASE (4 MONTHS) FOR THE TREATMENT OF PULMONARY TUBERCULOSIS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
A Placebo-controlled, Phase 2 Trial to Evaluate OPC 67683 in Patients With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB) : A Multi center, Randomized, Double-blind, Placebo-controlled Phase 2 Trial to Evaluate the Safety, Efficacy and Pharmacokinetics of Multiple Doses of OPC-67683 in Patients with Pulmonary Sputum Culture-Positive, Multidrug-resistant Tuberculosis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
AN INTERNATIONAL MULTICENTRE CONTROLLED CLINICAL TRIAL TO EVALUATE 1200MG AND 1800MG RIFAMPICIN DAILY IN THE REDUCTION OF TREATMENT DURATION FOR PULMONARY TUBERCULOSIS FROM 6 MONTHS TO 4 MONTHS (RIFASHORT) : AN INTERNATIONAL MULTICENTRE CONTROLLED CLINICAL TRIAL TO EVALUATE 1200MG AND 1800MG RIFAMPICIN DAILY IN THE REDUCTION OF TREATMENT DURATION FOR PULMONARY TUBERCULOSIS FROM 6 MONTHS TO 4 MONTHS (RIFASHORT)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
RIFAPENTINE-CONTAINING TUBERCULOSIS TREATMENT SHORTENING REGIMENS : RIFAPENTINE-CONTAINING TREATMENT SHORTENING REGIMENS FOR PULMONARY TUBERCULOSIS:A RANDOMIZED, OPEN-LABEL, CONTROLLED PHASE 3 CLINICAL TRIAL
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
INTERNATIONAL MULTICENTRIC TEST FOR THE EVALUATION OF A COMBINED TABLET OF FOUR DRUGS AT DAILY FIXED DOSE IN THE INTENSIVE INITIAL PHASE (2 MONTHS) OF CHEMOTHERAPY FOLLOWED BY A COMBINED TABLET OF TWO DRUGS AT A FIXED DOSE THREE TIMES A WEEK IN THE CONTINUATION PHASE (4 MONTHS) FOR THE TREATMENT OF PULMONARY TUBERCULOSIS : INTERNATIONAL MULTICENTRIC TEST FOR THE EVALUATION OF A COMBINED TABLET OF FOUR DRUGS AT DAILY FIXED DOSE IN THE INTENSIVE INITIAL PHASE (2 MONTHS) OF CHEMOTHERAPY FOLLOWED BY A COMBINED TABLET OF TWO DRUGS AT A FIXED DOSE THREE TIMES A WEEK IN THE CONTINUATION PHASE (4 MONTHS) FOR THE TREATMENT OF PULMONARY TUBERCULOSIS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
A Placebo-controlled, Phase 2 Trial to Evaluate OPC 67683 in Patients With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB) : A Multi center, Randomized, Double-blind, Placebo-controlled Phase 2 Trial to Evaluate the Safety, Efficacy and Pharmacokinetics of Multiple Doses of OPC-67683 in Patients with Pulmonary Sputum Culture-Positive, Multidrug-resistant Tuberculosis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
Efficacy of N-acetylcysteine for sputum smear conversion in pulmonary tuberculosis; multicenter open- label pragmatic randomized controlled trial : Efficacy of N-acetylcysteine for sputum smearconversion in pulmonary tuberculosis; multicenteropen- label pragmatic randomized controlled trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
Simvastatin and sputum conversion in pulmonary tuberculosis: a double-blinded randomized controlled trial : Simvastatin and sputum conversion in pulmonary tuberculosis: a double-blinded randomized controlled trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
Nächster »
[10]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Medienart
100
Aufsätze
100
E-Artikel
100
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
100
610
84
Study Type: Interventional
38
Recruitment Status: Completed
32
Recruitment Status: Not yet recruiting
20
Phase: Phase 2
18
Phase: Phase 3
18
Recruitment Status: Recruiting
8
Phase: Phase 4
8
Study Type: Observational
6
Medical Condition: -A150 Tuberculosis of lung, ...
6
Phase: Phase 2/Phase 3
6
Study Type: PMS
4
Medical Condition: Chronic obstructive pulmonar...
4
Medical Condition: Tuberculosis. Tuberculosis o...
4
Phase: Post Marketing Surveillance
4
Recruitment Status: Authorised-recruitment may ...
2
Medical Condition: -A150 Tuberculosis of lung, ...
2
Medical Condition: Acute bronchitis and purulen...
2
Medical Condition: Acute respiratory infection ...
2
Medical Condition: Asthma with sensitization to...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
58
2020-
42
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
98
Englisch
2
Spanisch
Haven't found what you're looking for?
Wird geladen...